Blausiegel

Blau Farmacêutica, formerly known as Blausiegel, is a leading Brazilian pharmaceutical company specializing in the institutional and hospital markets. The company focuses on high-complexity therapeutic areas including oncology, hematology, nephrology, and immunology. Blau is a pioneer in biotechnology in Latin America, producing a range of biologics, biosimilars, and specialized small molecule injectables. With multiple manufacturing plants and a robust R&D center, the company serves both the Brazilian market and international regions. It is publicly traded on the B3 exchange and maintains a significant portfolio of proprietary and generic hospital-grade medications.